LBT Innovations devises far-reaching solutions for the world’s emerging pathology needs

LBT Innovations is a leading developer of smart clinical and diagnostic technologies for the global pathology market.

Since its formation in 2004, LBT’s sophisticated automation technology has been installed in some of the world’s largest hospitals and clinical microbiology laboratories – where it is optimising workflows and delivering faster, more accurate results for thousands of patients.

With the commercialisation of its second product, LBT is cementing its reputation as a significant innovator for the next generation of global healthcare.

Click the links for videos showcasing the PREVI Isola and APAS technology

Company Overview
Over the past decade, LBT Innovations Ltd has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant be...
Read More
Since 2009, LBT’s MicroStreak technology has captured the largest share of the international market for automated culture-plate streaking and inoculation. The sophisticated streaker, sold by bioMérieux ...
Read More
The Automated Plate Assessment System, or APAS, is a platform technology for the automation of culture-plate screening and interpretation. While LBT’s first product, PREVI Isola, automates the inoculati...
Read More
Clever Culture Systems AG is a joint venture vehicle that brings together two highly complementary skill-sets: LBT Innovations’ patented image interpretation technology and in-depth understanding of the...
Read More